[Appearance of sulfasalazine and sulfapyridine in breast milk and in the placental barrier as well as the effect of both substances on bilirubin binding to albumin].
D001663:Bilirubin / Q000097:blood*; D003092:Colitis / Q000188:drug therapy; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D008895:Milk, Human / Q000378:metabolism*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D012709:Serum Albumin / Q000378:metabolism*; D013424:Sulfanilamides / Q000097:blood*; D013427:Sulfapyridine / Q000097:blood* / Q000627:therapeutic use; D012460:Sulfasalazine / Q000097:blood* / Q000627:therapeutic use
D012709:Serum Albumin; D013424:Sulfanilamides; D012460:Sulfasalazine; D001663:Bilirubin; D013427:Sulfapyridine
Ubertritt von Sulfasalazine und Sulfapyridin in die Muttermilch und durch die Plazentarschranke sowie der Einfluss der beiden Substanzen auf die Bilirubinbindung an Albumin.